Results 21 to 30 of about 104,742 (284)

Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer

open access: yesChinese Journal of Lung Cancer, 2015
Background and objective Carbonic anhydrase IX (CAIX) is widely expressed in a variety of malignant tumors, including-lung cancer. Our previous study has shown that the serum level of soluble form of carbonic anhydrase IX (s-CAIX) was significantly ...
Lina PENG   +4 more
doaj   +1 more source

The role of tumor necrosis factor alpha in differentiation between malignant and non malignant pleural effusion

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2016
Background: Despite the fact that Light’s criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for establishing the cause of pleural effusion to differentiate types of pleural
Heba M. Atef   +3 more
doaj   +1 more source

Malignant Pleural Effusion and Its Current Management: A Review

open access: yesMedicina, 2019
Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a common symptom and accompanying manifestation of metastatic disease.
Kristijan Skok   +3 more
semanticscholar   +1 more source

Tissue resident memory T cells are enriched and dysfunctional in effusion of patients with malignant tumor

open access: yesJournal of Cancer, 2023
Purpose Most malignant effusion is secondary to metastases to the pleura or peritoneum and portend poor oncological outcomes. Malignant effusion has different tumor microenvironment from primary tumor, containing a variety of cytokines and immune cells ...
Xueying Mao   +9 more
semanticscholar   +1 more source

Management of malignant pleural effusions [PDF]

open access: yesEuropean Respiratory Journal, 2001
⇓Malignant pleural effusions are a common clinical problem in patients with neoplastic disease. In one post mortem series, malignant effusions were found in 15% of patients who died with malignancies 1. Although there have been no epidemiological studies, the annual incidence of malignant pleural effusions in the United States is estimated to be >150 ...
P. Astoul   +7 more
openaire   +3 more sources

Development and validation of the PET-CT score for diagnosis of malignant pleural effusion

open access: yesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
PurposeAlthough some parameters of positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG) and computed tomography (PET-CT) are somehow helpful in differentiating malignant pleural effusion (MPE) from benign effusions, no individual parameter ...
Min-Fu Yang   +11 more
semanticscholar   +1 more source

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax

open access: yesChinese Medical Journal, 2015
Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu   +10 more
doaj   +1 more source

The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer

open access: yesMolecular Medicine Reports, 2018
Malignant pleural effusion (MPE) is a severe medical condition, which can result in breathlessness, pain, cachexia and reduced physical activity. It can occur in almost all types of malignant tumors; however, lung cancer is the most common cause of MPE ...
Yao Chen, N. W. Mathy, Hongda Lu
semanticscholar   +1 more source

Contemporary best practice in the management of malignant pleural effusion

open access: yesTherapeutic Advances in Respiratory Disease, 2018
Malignant pleural effusion (MPE) affects more than 1 million people globally. There is a dearth of evidence on the therapeutic approach to MPE, and not surprisingly a high degree of variability in the management thereof.
C. Koegelenberg   +3 more
semanticscholar   +1 more source

Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2015
The glycoprotein YKL-40 is synthesized both by cancer cells and by tumor-associated macrophages and plays a functional role in tumor progression. Consequently, high serum YKL-40 levels have been associated with a poor prognosis in patients with several ...
Adel Attia   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy